Among the factors that can promote BAT dysfunction in obesity is the reduction of vascularization and, consequently, the β-adrenergic activation pathway that regulates the BAT activity, favoring Ucp1 expression [88,89,90], and stimulates the lipolytic pathway to mobilize fatty acids for oxidation [91]. Here, UCP1 is linked to obesity due to melanocortin 4 receptor deficiency.